Contact & Appointment Information
Department: Oncology
About Dr. Mark T. Fleming, M.D.
Advancing Cancer Care with Research and Kindness
In oncology, science moves fast to beat cancer. Doctors blend top knowledge with steady care. Dr. Mark T. Fleming leads this effort. He is a top expert in urinary tract cancers. His work improves treatment, research, and patient support.
Dr. Mark T. Fleming ranks among America’s top 50 doctors. He joins clinical skills with fresh research. His path shows a strong drive to treat cancer. He also changes how we study and beat it.
Solid Start in School
Dr. Mark T. Fleming built a firm base in medicine. He got his BA from the University of Pennsylvania. It is a top Ivy League school.
He earned his MD at the Medical University of Ohio. There, he grew keen on cancer and internal medicine. His training stressed science, patient focus, and research gains.
Residency and Fellowship at Top Centers
After med school, he did a residency at Temple University Hospital in Philadelphia. He learned much about internal medicine and tough cases.
Next, he joined Memorial Sloan Kettering Cancer Center in New York. It offers world-class cancer training. There, he finished his oncology fellowship.
At Sloan Kettering, he studied:
New cancer treatments, Trial design and runs, Team-based cancer care, New oncology options
This top setting formed him as a doctor and researcher.
Start at Virginia Oncology Associates
Dr. Mark T. Fleming joined Virginia Oncology Associates in August 2006. He still works there and leads new treatment plans.
At VOA, he gives full cancer care. He also runs research that brings fresh treatments to patients.
Focus on Urinary Tract Cancers
Dr. Mark T. Fleming treats genitourinary cancers like:
Bladder cancer Kidney cancer Prostate cancer Testicular cancer
These need special skills. Treatments change often due to their tough nature.
His skills let him:
Make custom treatment plans, add new therapies, handle late-stage cases, and offer top trials
Lead in Research Trials
Clinical research marks Dr. Mark T. Fleming’s career.
He leads many trials as principal investigator. He works with groups like:
Duke University Network, Hoosier Oncology Group, Prostate Cancer Trials Consortium, US Oncology Research
These ties help patients get new treatments close by.
Key Work on New Treatments
Dr. Mark T. Fleming helped write key studies. They led to new drug approvals.
Enzalutamide for Prostate Cancer
A New England Journal of Medicine paper showed it boosts survival. It helps prostate patients after chemo.
Atezolizumab for Bladder Cancer
The Lancet study proved immunotherapy works for the spread of bladder cancer.
Combo Therapy Study
His Phase 1 work in Clinical Cancer Research tested enzalutamide with docetaxel. It checked the safety and effect.
These efforts changed treatments worldwide. They help patients everywhere.
Expert in Early Drug Tests
Dr. Mark T. Fleming drives Phase 1 trials. These test new cancer drugs first in people.
He works on:
Safety and dose checks, Spotting strong new drugs, New drug mixes
This moves lab drugs to real use.
Top Name in GU Oncology
Experts see Dr. Mark T. Fleming as a national leader in urinary cancers.
He has:
Joined ASCO’s guideline network, moderated at ASCO meetings Sat on drug company boards
His views guide U.S. rules and cancer care ahead.
Papers and Talks
Dr. Fleming adds much to med journals like:
Clinical Cancer Research, Nature Clinical Practice, Oncology Update in Clinical Therapeutics, Clinical Prostate Cancer
He wrote book parts too. He spoke at events like:
ASCO SIOG Duke and EVMS talks
This shows his push to grow cancer knowledge.
Key Roles in Medicine
Dr. Fleming leads past research and care.
He was:
Head of Hematology & Oncology at Eastern Virginia Medical School, Medical Staff President at Sentara CarePlex Hospital, Director of US Oncology’s GU Research Committee
He helps run VOA research, too.
Push for Cancer Checks
Dr. Fleming fights for cancer education and early detection, especially prostate.
He co-founded and led the Hampton Roads Prostate Health Forum. He works to:
Boost prostate awareness Push early tests Teach on risks
His efforts aid early catches and better results.
Focus on Patients
Research and leads do not pull him from patients.
Dr. Fleming offers:
Custom plans, Clear talks with patients and kin, Newest treatments, Emotional help
Cancer hits hard. He supports folks through it.
Oncology Today
Cancer care changes quickly with:
Immunotherapy, Targeted drugs, Exact medicine, Gene tests
Dr. Fleming keeps up. His patients get the best new science.
Life Beyond Work
Dr. Fleming likes family and town time off duty.
He enjoys:
Time with family, Church work, Golf, Cleveland teams
These keep the balance in his key job.
Final Reflection
Mark T. Fleming’s career leads modern oncology. Research, new ideas, and kind care meet there.
He started school at the University of Pennsylvania. He trained more at Memorial Sloan Kettering. Now he leads at Virginia Oncology Associates. Dr. Fleming shows top skill in all his work.
His work in cancer research helps genitourinary cancers the most. It boosts patient results. It grows knowledge of cancer care worldwide.
Dr. Fleming’s legacy comes from steady care for patients. He loves finding new truths. He works for a time when cancer is easy to handle, not deadly.
FAQs
Q. Who is Mark T. Fleming, MD?
Mark T. Fleming is a board-certified medical oncologist. He treats genitourinary cancers in Virginia.
Q. Does Dr. Fleming lead research programs?
Yes. He is Medical Director of US Oncology’s Genitourinary Research Committee.
Q. Is he involved in national medical organizations?
Yes. He joins ASCO and helps write its guidelines.
Q. Is Dr. Fleming involved in cancer awareness?
Yes. He co-founded and led the Hampton Roads Prostate Health Forum.
Q. What is his approach to patient care?
It centers on patients. It uses research. It offers advanced, personal treatments.
Q. Why is Dr. Fleming recognized as a top doctor?
His cancer research, oncology leadership, and patient care earn that honor.